Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IMPROVING SAFE PATIENT THROUGHPUT IN A MULTIDISCIPLINARY ONCOLOGY CLINIC.
Elnahal SM, Moningi S, Wild AT, Dholakia AS, Hodgin M, Fan KY, Huang P, Pronovost P, Pawlik TM, Herman JM. Elnahal SM, et al. Among authors: wild at. Physician Leadersh J. 2015 Mar-Apr;2(2):56-60, 62, 64-5. Physician Leadersh J. 2015. PMID: 26211213 No abstract available.
Management of pancreatic cancer.
Wild AT, Fan KY, Herman JM. Wild AT, et al. Curr Probl Cancer. 2013 Sep-Oct;37(5):259-61. doi: 10.1016/j.currproblcancer.2013.10.001. Epub 2013 Oct 7. Curr Probl Cancer. 2013. PMID: 24331179 No abstract available.
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.
Fan KY, Dholakia AS, Wild AT, Su Z, Hacker-Prietz A, Kumar R, Hodgin M, Hsu CC, Le DT, De Jesus-Acosta A, Diaz LA Jr, Laheru DA, Hruban RH, Fishman EK, Brown TD, Pawlik TM, Wolfgang CL, Tran PT, Herman JM. Fan KY, et al. Among authors: wild at. J Natl Compr Canc Netw. 2014 Jan;12(1):50-7. doi: 10.6004/jnccn.2014.0006. J Natl Compr Canc Netw. 2014. PMID: 24453292 Free PMC article.
Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas.
Wild AT, Dholakia AS, Fan KY, Kumar R, Moningi S, Rosati LM, Laheru DA, Zheng L, De Jesus-Acosta A, Ellsworth SG, Hacker-Prietz A, Voong KR, Tran PT, Hruban RH, Pawlik TM, Wolfgang CL, Herman JM. Wild AT, et al. J Gastrointest Oncol. 2015 Apr;6(2):115-25. doi: 10.3978/j.issn.2078-6891.2014.091. J Gastrointest Oncol. 2015. PMID: 25830031 Free PMC article.
Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer.
Wild AT, Herman JM, Dholakia AS, Moningi S, Lu Y, Rosati LM, Hacker-Prietz A, Assadi RK, Saeed AM, Pawlik TM, Jaffee EM, Laheru DA, Tran PT, Weiss MJ, Wolfgang CL, Ford E, Grossman SA, Ye X, Ellsworth SG. Wild AT, et al. Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):571-9. doi: 10.1016/j.ijrobp.2015.11.026. Epub 2015 Dec 1. Int J Radiat Oncol Biol Phys. 2016. PMID: 26867885 Free PMC article. Clinical Trial.
Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor-vessel relationships.
Dholakia AS, Hacker-Prietz A, Wild AT, Raman SP, Wood LD, Huang P, Laheru DA, Zheng L, De Jesus-Acosta A, Le DT, Schulick R, Edil B, Ellsworth S, Pawlik TM, Iacobuzio-Donahue CA, Hruban RH, Cameron JL, Fishman EK, Wolfgang CL, Herman JM. Dholakia AS, et al. Among authors: wild at. J Radiat Oncol. 2013 Dec;2(4):413-425. doi: 10.1007/s13566-013-0115-6. Epub 2013 Sep 22. J Radiat Oncol. 2013. PMID: 25755849 Free PMC article.
Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.
Herman JM, Fan KY, Wild AT, Hacker-Prietz A, Wood LD, Blackford AL, Ellsworth S, Zheng L, Le DT, De Jesus-Acosta A, Hidalgo M, Donehower RC, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Wolfgang CL. Herman JM, et al. Among authors: wild at. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):678-85. doi: 10.1016/j.ijrobp.2013.03.032. Int J Radiat Oncol Biol Phys. 2013. PMID: 23773391 Free PMC article. Clinical Trial.
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.
Herman JM, Fan KY, Wild AT, Wood LD, Blackford AL, Donehower RC, Hidalgo M, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Iacobuzio-Donahue CA, Wolfgang CL. Herman JM, et al. Among authors: wild at. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):458-9. doi: 10.1016/j.ijrobp.2013.06.2039. Int J Radiat Oncol Biol Phys. 2013. PMID: 24074918 Free PMC article. No abstract available.
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
Herman JM, Chang DT, Goodman KA, Dholakia AS, Raman SP, Hacker-Prietz A, Iacobuzio-Donahue CA, Griffith ME, Pawlik TM, Pai JS, O'Reilly E, Fisher GA, Wild AT, Rosati LM, Zheng L, Wolfgang CL, Laheru DA, Columbo LA, Sugar EA, Koong AC. Herman JM, et al. Among authors: wild at. Cancer. 2015 Apr 1;121(7):1128-37. doi: 10.1002/cncr.29161. Epub 2014 Dec 23. Cancer. 2015. PMID: 25538019 Free PMC article. Clinical Trial.
Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.
Fan KY, Wild AT, Halappa VG, Kumar R, Ellsworth S, Ziegler M, Garg T, Rosati LM, Su Z, Hacker-Prietz A, Pawlik TM, Cosgrove DP, Hong KK, Kamel IR, Geschwind JF, Herman JM. Fan KY, et al. Among authors: wild at. Contemp Clin Trials. 2016 Sep;50:143-9. doi: 10.1016/j.cct.2016.08.001. Epub 2016 Aug 9. Contemp Clin Trials. 2016. PMID: 27520932
40 results